Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and even a stall in research and development.

Let's discuss whether Vertex Pharmaceuticals stock is a buy ... expected this year could be a catalyst for the stock. Image source: Getty Images. With cystic fibrosis therapies remaining the ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released clinical trial results for its oral ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

The major U.S. equities indexes were mixed at midday Thursday, with the Dow Jones Industrial Average down close to 400 points ...

The Dow Jones Industrial Average fell by more than 300 points on Tuesday, with the S&P 500 and Nasdaq Composite also down by ...

Lawyers representing different groups of women are looking to a Houston bankruptcy judge to reverse a March 31 ruling.

Sangamo Therapeutics shares are surging in Thursday's after-hours session after the company announced a new agreement with pharmaceutical giant Eli Lilly And Co.

Image source: Getty Images. There are even different regulatory paths for biotech and pharma products in the U.S. Companies that develop therapies made from living organisms must file a Biologics ...